GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transgene Biotek Ltd (BOM:526139) » Definitions » Margin of Safety % (DCF FCF Based)

Transgene Biotek (BOM:526139) Margin of Safety % (DCF FCF Based) : N/A (As of Mar. 31, 2025)


View and export this data going back to 2001. Start your Free Trial

What is Transgene Biotek Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Transgene Biotek's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

Competitive Comparison of Transgene Biotek's Margin of Safety % (DCF FCF Based)

For the Biotechnology subindustry, Transgene Biotek's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Transgene Biotek's Margin of Safety % (DCF FCF Based) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Transgene Biotek's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Transgene Biotek's Margin of Safety % (DCF FCF Based) falls into.


;
;

Transgene Biotek Margin of Safety % (DCF FCF Based) Related Terms

Thank you for viewing the detailed overview of Transgene Biotek's Margin of Safety % (DCF FCF Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Transgene Biotek Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transgene Biotek Ltd (BOM:526139) » Definitions » Margin of Safety % (DCF FCF Based)
Comparable Companies
BOM:514336 BOM:506365 BOM:539206 BOM:524238 BOM:531207 BOM:511509 BOM:542910 BOM:532890 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX SMMT INSM
Traded in Other Exchanges
N/A
Address
Anrich Industrial Area, Plot No. 69 and 70, IDA Bollaram, Sangareddy District, Medak, TG, IND, 502325
Website
https://www.transgenebiotek.com
Transgene Biotek Ltd is an India-based research and development company. It is engaged in the research and development of molecules and technologies for the production of active pharmaceutical ingredients and other pharmaceutical products. The company is operating only in one segment of Bulk Drugs. Its product portfolio includes TrabiDHA, Tracolimus, and Orlistat. It generates revenue from the sale of goods and services.

Transgene Biotek Headlines

No Headlines